1-hydroxymethylmidazolam has been researched along with everolimus in 1 studies
| Studies (1-hydroxymethylmidazolam) | Trials (1-hydroxymethylmidazolam) | Recent Studies (post-2010) (1-hydroxymethylmidazolam) | Studies (everolimus) | Trials (everolimus) | Recent Studies (post-2010) (everolimus) |
|---|---|---|---|---|---|
| 163 | 46 | 49 | 5,631 | 1,289 | 4,579 |
| Protein | Taxonomy | 1-hydroxymethylmidazolam (IC50) | everolimus (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 2 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0022 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouillaud, E; Cheung, W; Delaney, R; Jappe, A; Urva, S | 1 |
1 trial(s) available for 1-hydroxymethylmidazolam and everolimus
| Article | Year |
|---|---|
A phase I study evaluating the effect of everolimus on the pharmacokinetics of midazolam in healthy subjects.
Topics: Adult; Anti-Anxiety Agents; Drug Interactions; Everolimus; Humans; Hypnotics and Sedatives; Immunosuppressive Agents; Male; Midazolam; Middle Aged; Sirolimus; Young Adult | 2013 |